Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild-To-Moderate Alzheimer's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01955161
What this trial is testing

Study of Idalopirdine in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil

Who this might be right for
Alzheimer's Disease
H. Lundbeck A/S 933
Large-scale testing (Phase 3)UnknownNCT00088673
What this trial is testing

Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Bellus Health Inc. - a GSK company 950
Large-scale testing (Phase 3)Ended earlyNCT02248116
What this trial is testing

Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type

Who this might be right for
Alzheimer Disease
Boehringer Ingelheim 198
Large-scale testing (Phase 3)Ended earlyNCT01739348
What this trial is testing

An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)

Who this might be right for
Alzheimer's Disease
Merck Sharp & Dohme LLC 2,211
Large-scale testing (Phase 3)Study completedNCT00104013
What this trial is testing

Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Sanofi 1,455
Testing effectiveness (Phase 2)Study completedNCT00224497
What this trial is testing

A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 380
Testing effectiveness (Phase 2)Study completedNCT01466088
What this trial is testing

Efficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)

Who this might be right for
Alzheimer's Disease
Targacept Inc. 386
Testing effectiveness (Phase 2)Study completedNCT01397578
What this trial is testing

Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Genentech, Inc. 91
Testing effectiveness (Phase 2)Study completedNCT00265148
What this trial is testing

Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 80
Testing effectiveness (Phase 2)Ended earlyNCT01712074
What this trial is testing

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

Who this might be right for
Alzheimer's Disease
Pfizer 186
Large-scale testing (Phase 3)Study completedNCT01561053
What this trial is testing

Evaluate Albumin and Immunoglobulin in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Instituto Grifols, S.A. 347
Testing effectiveness (Phase 2)Study completedNCT00357357
What this trial is testing

European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Hunter-Fleming Ltd 40
Large-scale testing (Phase 3)Study completedNCT04488419
What this trial is testing

ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseDementia of Alzheimer Type
LeonaBio 554
Early research (Phase 1)Study completedNCT02910739
What this trial is testing

An Open-Label Study Investigating MK-8931 in Participants With Mild and Moderate Hepatic Insufficiency (MK-8931-016)

Who this might be right for
Amnestic Mild Cognitive ImpairmentAlzheimer's DiseaseProdromal Alzheimer's Disease
Merck Sharp & Dohme LLC 16
Testing effectiveness (Phase 2)Study completedNCT02907567
What this trial is testing

Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Cognition Therapeutics 19
Testing effectiveness (Phase 2)Study completedNCT01137526
What this trial is testing

Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
AbbVie (prior sponsor, Abbott) 267
Testing effectiveness (Phase 2)UnknownNCT00154635
What this trial is testing

Efficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Dementia, Alzheimer Type
National Taiwan University Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00151333
What this trial is testing

Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Wyeth is now a wholly owned subsidiary of Pfizer 16
Testing effectiveness (Phase 2)Ended earlyNCT00960531
What this trial is testing

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Pfizer 160
Large-scale testing (Phase 3)Study completedNCT01689246
What this trial is testing

Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
TauRx Therapeutics Ltd 891
Next Page